Join a comprehensive conference session from the 2023 Rare Cardiac Conditions Conference focused on cardiac amyloidosis, moderated by cardiologists Dr. Ian Paterson and Dr. Nowell Fine. Explore three fascinating case studies presented by leading physicians from Canadian institutions, followed by in-depth discussions on ongoing clinical trials and emerging therapies in both ATTR and AL amyloidosis. Learn about the latest updates from the Canadian registry for amyloidosis research, and delve into patient-reported outcomes through literature review, questionnaire analysis, and the development of specific PRO forms for AL and ATTR conditions. Gain valuable insights from expert cardiologists and researchers across major Canadian medical institutions as they share their knowledge and experiences in treating and studying this rare cardiac condition.
Cardiac Amyloidosis: Clinical Cases, Therapies, and Patient Outcomes
University of Ottawa Heart Institute via YouTube
Overview
Syllabus
- Case 1: Dr. Betty Mengesha, University of Ottawa Heart Institute
- Case 2: Dr. Waseem Hijazi, University of Calgary
- Case 3: Dr. Kai Wu, University of Alberta
- ATTR: Dr. François Tournoux, Université de Montréal
- AL: Dr. Alissa Visram, University of Ottawa
- Update on the Canadian registry for amyloidosis research: Dr. Nowell Fine
- Review existing literature on PRO: Dr. Ian Paterson
- Review CRAR patient questionnaires: Dr. Nowell Fine
- Develop AL and ATTR specific PRO forms: All
Taught by
University of Ottawa Heart Institute
